This article represents the first attempt to perform a pooled analysis about remote ischaemic preconditioning (RIPC) in reduction of acute kidney injury (AKI) of adult patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). A systematic search was performed using PubMed (1966( -5 January 2016, the Cochrane Library (1996-5 January 2016), the Web of Science (1986-5 January 2016) and Chinese database (SinoMed) (1978( -5 January 2016 to identify studies that have described the effect of RIPC on AKI in adult patients undergoing cardiac surgery with CPB. The outcomes used for this analysis included the incidence of AKI and the need for renal replacement therapy (RRT). Thirteen randomized controlled trials (4370 participants) were included in this analysis. RIPC significantly reduced the risk of AKI (risk ratio, 0.81; 95% confidence interval, [0.66, 0.99]; P = 0.04; I 2 = 46%) for adult patients compared with control group. However, there was no significant difference with respect to the incidence of RRT between the two groups. The present meta-analysis found that RIPC may reduce the incidence of AKI among adult patients following cardiac surgery with CPB. Adequately powered trials are warranted to provide further corroboration of our findings in the future.
INTRODUCTION
Remote ischaemic preconditioning (RIPC), which involves multiple brief episodes of mild ischaemia and reperfusion to a remote organ/tissue that offer protection against subsequent lethal ischaemia-reperfusion injury to the target organ [1] , may provide a novel non-pharmacological prevention strategy for reducing the incidence of acute kidney injury (AKI), a common and serious complication during cardiac surgery with cardiopulmonary bypass (CPB) [2] [3] [4] . First clinically applied in children with congenital heart disease [5] , RIPC has been rapidly translated to adult patients undergoing surgical interventions, including abdominal aneurysm repair [6] and coronary artery bypass grafting (CABG) [7] . Currently, multiple clinical trials analysing the effects of RIPC on AKI linked to cardiovascular surgery have been published [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . Likewise, several meta-analyses have attempted to determine whether or not RIPC reduces the incidence of AKI following cardiovascular surgery [22, 23] . However, the conclusions from these meta-analyses remain inconsistent, probably due to the following: (i) the subjects selected in these studies included a mixture of adult and paediatric patients; it is well known that paediatric patients have immature organs, and a certain maturation of the kidneys is a prerequisite for a response to RIPC [24, 25] ; and (ii) the cardiovascular surgeries included those with and without CPB. Based on our clinical experience, a CPB is more necessary in cases involving a complicated surgery or more severe cardiac disease; therefore, including surgeries with and without CPB produced a confounding issue to the outcomes. The present analysis represented the first attempt to perform a pooled analysis of the effects of RIPC on the incidence of AKI in adult patients undergoing cardiac surgery with CPB in randomized controlled trials (RCTs). †The first three authors contributed equally to this study.
MATERIALS AND METHODS
This meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines [26] .
Search strategy
All RCTs of RIPC versus control (without RIPC) that enrolled patients undergoing cardiac surgery with CPB were identified. The PubMed (1966-5 January 2016), Cochrane Library (1996-5 January 2016), Web of Science (1986-5 January 2016) and Chinese database (SinoMed) (1978-5 January 2016) were searched. The Medical Subject Heading terms and/or text words entered were 'ischaemic preconditioning', 'remote ischaemic preconditioning', 'cardiac surgical procedure', 'cardiovascular surgical procedures', 'coronary artery bypass', 'heart valve prosthesis implantation', 'randomized controlled trial' and 'controlled clinical trial'. All references mentioned in the identified original articles were reviewed by hand searching to identify additional nonindexed literature. There were no language restrictions. The titles and abstracts of the articles from these searches were independently analysed by two of the authors to ascertain that the inclusion criteria were met. The full text of an article was reviewed carefully if its title and abstract screening was ambiguous with regard to its inclusion.
Study selection and outcome measures
The studies considered for inclusion met all of the following criteria: (i) they were RCTs; (ii) the intervention was RIPC or not; (iii) trial participants were all adults (> _18 years old), who underwent any type of cardiac surgery with CPB; and (4) the studies reported the incidence of the outcome of interest, that is, AKI events after cardiac surgery (including zero events) in both groups.
We excluded the following studies: (i) those containing overlapping data; (ii) those in which numeric data could not be ascertained; (iii) those including paediatric patients; (iv) those using vascular interventions, including surgical and non-surgical procedures; and (5) those using off-pump cardiac surgery. When duplicate reports of the same study were found in the preliminary abstracts and articles, data from the most complete data set were selected.
The primary outcome measure was the incidence of AKI. The secondary outcome measure was the need for renal replacement therapy (RRT).
Quality assessment
Two reviewers independently validated each study with Cochrane Collaboration's tool to assess the risk of bias [27] , which addressed 10 specific domains such as sequence generation, allocation concealment, blinding, incomplete outcome data and selective outcome reporting. The disagreements, if any, were resolved by a third reviewer.
Data extraction
After data assessment and reaching a consensus for the eligible studies by using a standardized data extraction form, the data were independently extracted from the original studies by two reviewers, and discrepancies between reviewers were clarified through re-evaluation and discussion. The following information was extracted from each study: first author, year of publication, demographic characteristics of patients, type of surgical procedure, the protocol for RIPC, the protocol for control groups, definition of AKI, incidence of AKI and the need for RRT. The corresponding authors of the included studies were contacted directly for additional data, if necessary.
Data analysis
Risk ratios (RRs) with 95% confidence intervals (CIs) for dichotomous outcomes were calculated [27] . To determine the robustness of our pooled effects, we performed our meta-analysis with random-effects models by the inverse variance method. The results were presented graphically using a forest plot graph or table.
Cochran's Q-statistics were used to assess within and between study variations. Heterogeneity was quantified using I 2 , which ranged from 0 to 100% and represented the proportion of between study variability attributable to heterogeneity rather than chance. I 2 values of 25%, 50% and 75% were nominally considered low, moderate and high estimates, respectively [28] . Changing the models and statistical methods were employed to perform sensitivity analysis. The following sub-group analyses were performed: (i) the definitions of AKI applied [AKI Network (AKIN) versus non-AKIN criterion], (ii) the limb used in RIPC (upper only versus lower limbs) and (iii) the total duration of ischaemia (> _20 vs <20 min). All statistical analyses were performed using Review Manager 5.2 (Cochrane Collaboration, London, UK) [27] .
RESULTS

Search results and study characteristics
A total of 611 studies were uncovered during the initial search, including 234 from PubMed, 181 from the Cochrane Library, 144 from the Web of Science and 52 from Chinese database (SinoMed). Among these 611 studies, 292 duplicate studies were removed, and 295 studies were excluded because they were either non-randomized studies or had patients, interventions, outcomes or study designs that were not relevant to this review. Eventually, a full-text assessment of 24 potentially relevant studies identified 13 eligible trials ( Fig. 1 ) [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] ; all 13 were full-length articles.
A total of 4370 participants were enrolled in these 13 studies, including one involving CABG surgery [10] , two involving valvular heart surgery [20, 21] and 10 involving CABG and/or valvular heart surgery [9, [11] [12] [13] [14] [15] [16] [17] [18] [19] . The RIPC methods used in these studies varied: (i) nine studies used an inflatable tourniquet around the upper limbs only [9, 10, 13-17, 19, 20] , three used an inflatable tourniquet around the lower limbs [11, 12, 21] , and one used an inflatable tourniquet around the upper and lower limbs [18] ; (ii) eight studies used a total duration of ischaemia of <20 min [9-11, 13, 17, 9-21] , and five used a total duration of ischaemia of > _20 min [12, [14] [15] [16] 18] . The patients in control groups did not suffer from any limbs ischaemia in all 13 studies. The key characteristics of the included studies are summarized in Table 1 .
Quality assessment
All the trials were RCTs, and most of them reported the details of randomization and allocation concealment. The overall details of quality assessment, which was the risk of bias summary, are listed in Table 2 .
Study outcomes
Incidence of acute kidney injury Data regarding AKI incidence were available for all 13 trials included in the meta-analysis [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . Adult patients undergoing cardiac surgery with CPB had a significantly lower risk of AKI in the RIPC group than in the control group (13 trials; 4370 participants; RR, 0.81; 95% CI, [0.66, 0.99]; P = 0.04; I 2 = 46%; Fig. 2 ). The analysis of the pooled effect sizes was moderately heterogeneous (I 2 = 46%). The funnel plot of the standard error by log RR did not suggest the presence of a publication bias (Fig. 3) .
Sub-group analysis
During the analysis, we noticed that different definitions of AKI had been applied by the investigators of the respective studies. The definitions included (i) the AKIN criteria, which is defined as any of the following: an elevation of serum creatinine (SCr) of > _0.3mg/dl or > _50% within 48 h; or urine output <0.5 ml/kg/h for >6 h [29] , (ii) risk, injury, failure, loss and end-stage kidney (RIFLE) criteria, which is defined as any of the following: increased SCr Â 1.5; or glomerular filtration rate decrease > 25%; or urine output <0.5 ml/kg/h for >6 h [30] , (iii) the Kidney Disease: Improving Global Outcomes (KDIGO) criteria, which is defined as any of the following: increase in SCr by > _0.3 mg/dl (> _26.5 lmol/l) within 48 h; or increase in SCr to > _1.5 times baseline, which is known or presumed to have occurred within the prior 7 days; or urine output<0.5 ml/kg/h for>6 h [31] , and others. Thus, we analysed the sub-groups of the trials based on the AKIN criteria and non-AKIN criteria, respectively, the latter of which was a combination of the RIFLE, KDIGO and others, to evaluate the efficacy of RIPC for AKI prevention. The test for sub-group differences is shown in Table 3 (X 2 = 2.09, df = 1 (P = 0.15), I 2 = 52.1%). RIPC significantly reduced the risk of AKI as defined by the AKIN (eight trials; 868 participants; RR, 0.69; 95% CI, [0.50, 0.96]; P = 0.03; I 2 = 36%) [9, 11, 12, 14, [18] [19] [20] [21] , but failed to significantly decrease the risk of AKI as defined by the non-AKIN criteria (five trials; 3176 participants; RR, 0.92; 95% CI, [0.75, 1.33]; P = 0.43; I 2 = 35%) [10, 13, [15] [16] [17] . Hence, we conclude that the efficacy of RIPC in decreasing the risk of AKI is associated with the AKI definition.
Next, we analysed the detailed RIPC protocols used by these studies. As shown in Table 1 , all 13 trials used a tourniquet cuff around the limbs for the RIPC [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . Sub-group analysis indicated that there was high heterogeneity in the risk estimate for AKI incidence, regardless of whether only upper or lower limbs (2015); however, the drop-out rate was acceptable. Therefore, we chose the final reported numbers of patients (numbers in Fig 2) rather than the first included numbers of patients (numbers in Table 1 ) in our meta-analysis.
were used in the RIPC (test for sub-group differences: X 2 = 4.79, df = 1 (P = 0.03), I 2 = 79.1%; Table 3 ). There was a significant difference when lower limbs were used in the RIPC (four trials; 425 participants; RR, 0.56; 95% CI, [0.36, 0.87]; P = 0.01; I 2 = 40%) [11, 12, 18, 21] ; whereas no significant difference was observed between these two groups when only upper limbs were used (nine trials; 3619 participants; RR, 0.94; 95% CI, [0.82, 1.08]; P = 0.37; I 2 = 7%) [9, 10, 13-17, 19, 20] . Likewise, we also found a positive correlation between different durations of ischaemia used in the RIPC and the incidence of AKI [test for sub-group differences: X 2 = 5.20, df = 1 (P = 0.02), I 2 = 80.8%; Table 3 ]. There was a significant difference in the risk estimate for the AKI incidence when the total duration of ischaemia was <20 min (eight trials; 929 participants; RR, 0.70; 95% CI, [0.55, 0.88]; P = 0.003; I 2 = 15%) [9-11, 13, 17, 19-21] ; whereas no significant difference was seen between these two groups when the duration was > _20 min (five trials; 3115 participants; RR, 0.99; 95% CI, [0.82, 1.20]; P = 0.93; I 2 = 14%) [12, [14] [15] [16] 18] . These findings suggest that a duration of ischaemia <20 min during RIPC is beneficial for reducing the incidence of AKI during cardiac surgery with CPB.
Sensitivity analysis
Our analyses were robust in terms of the selection of the models and statistical methods. Substitution of a fixed-effect model (RR, 0.91; 95% CI, [0.82, 1.01]) for the random-effects model did not significantly alter our initial qualitative interpretation of the pooled treatment effect of RIPC on AKI following cardiac surgery with CPB.
Initiation of renal replacement therapy
Postoperative initiation of RRT was reported in eight trials [9-12, 17, 19-21] , and a total of 34 patients received RRT after cardiac surgery (12, RIPC group; 22, control group). There was no significant difference in the initiation of RRT between these two groups (RR, 0.82; 95% CI, [0.20, 3.39]; P = 0.78; I 2 = 47%; Fig. 4 ), suggesting that RIPC does not significantly reduce the incidence of the initiation of RRT in adult patients undergoing CPB.
DISCUSSION
In the present meta-analysis, we found that RIPC reduced the risk of AKI in adult patients undergoing cardiac surgery with CPB, compared with control individuals. However, we did not see any differences between the two groups with respect to the incidence of RRT. RIPC refers to a novel noninvasive, safe, convenient and low-cost therapeutic intervention for reducing the incidence of AKI among adult patients undergoing cardiac surgery with CPB. Accumulating evidence supports the notion of existing neural, humoral and systemic inflammatory mediators of signal transduction between the preconditioning stimulus and the target organ [32] , and oxidative and inflammatory injuries to renal tubular epithelial cells have been implicated in the mechanisms underlying the development of AKI during cardiac surgeries [2] . Therefore, although the kidneys are not exposed directly to ischaemia-reperfusion injury like the heart, RIPC may prevent AKI by attenuating the production of oxygen free radicals and the consequent activation of the inflammatory cascade during cardiac surgery.
The definitions of AKI used in the trials included in our metaanalysis were different; the AKI definitions included the AKIN criteria, RIFLE criteria, KDIGO criteria and others. Although all AKI definitions were similar, the conclusions drawn should be treated with caution. It is important to note that definition differences might influence the analysis outcomes. Indeed, the sub-group analyses showed that RIPC significantly reduced the risk of AKI as defined by the AKIN criteria but not that defined by the non-AKIN criteria. The results suggested that the level of injury was too minute to be detected by the other definitions as the only difference lay in a definition of AKI beginning at a rise of SCr of 0.3 mg/dl or > _50% strictly limited within 48 h. Although these results might not be robust enough to draw a conclusion due to the limited number of trials and small sample sizes, the conclusion itself should be taken with caution. Based on the results of our sub-group analyses, we recommend that it would be beneficial to carry out new RCTs with a standard AKI definition, the best of which is the AKIN criteria, to make a robust conclusion on the effects of RIPC on the AKI risk in adult patients undergoing cardiac surgery with CPB. The majority of trials included in our analysis used a standard single-limb RIPC protocol comprising either three or four 5-min cycles of inflation/deflation of a cuff placed on either the upper arm or thigh. One potential explanation for the differences among these 13 trials is related to the RIPC stimulus itself (in terms of site, number of cycles of RIPC and total duration of ischaemia). Therefore, to further understand how any of these three factors might have any influence on the outcomes of RIPC, we conducted sub-group analyses based on either the limb or the total duration of ischaemia used in the RIPC. Our findings suggested that both the limb and the total duration of ischaemia used were the covariates that contributed significantly to heterogeneity, as evidenced by the observations that using the lower limb and/or a total duration of ischaemia of <20 min was the most beneficial to the patients undergoing cardiac surgery with regard to AKI.
In the present analysis, we also assessed the postoperative RRT requirement. Surprisingly, we did not see any significant differences in this index between the two groups, given that RIPC significantly decreased the risk of AKI in these patients. Several reasons might potentially account for these negative findings. For instance, our analysis was limited due to the small number of trials and small sample sizes. Also, the baselines of kidney function of the patients included in these 13 studies were different. Because AKI was defined based on variation above a baseline, evaluating the variation in renal function indexes as opposed to a baseline may have a potential clinical significance.
However, there was not enough information available from the included trials to offer a conclusive answer for the above discrepancy.
We need to point out some limitations present in this metaanalysis. First, as described earlier, the AKI definitions and the RIPC protocols adopted in the included trials were different, although all the applied AKI definitions were similar, and the majority of trials used a standard single-limb RIPC protocol comprising either three or four 5-min cycles of inflation/deflation of a cuff placed on either the upper arm or thigh. In addition, we noted heterogeneity as revealed by using a random effects model and performing sub-group analyses.
Second, an increase in the SCr level remains the standard by which AKI is defined; however, the sensitivity of SCr levels to socalled prerenal states is a significant shortcoming, particularly after cardiac surgery, when patients often exhibit significant cardiovascular instability. Studies showing associations between AKI without requiring RRT and adverse clinical outcomes have used SCr concentrations to identify episodes of AKI and have not differentiated prerenal conditions from true kidney injury [33, 34] . Neutrophil gelatinase-associated lipocalin, another biomarker that is heavily expressed in the kidney shortly after ischaemic injury and is believed to be better than SCr in detecting AKI, appears not to be sensitive to haemodynamic changes and has been used as a plasma biomarker for AKI in paediatric and adult cardiac surgery patients [35, 36] . However, the related raw data from these trials were deficient, which prevented us from performing a meta-analysis to accurately evaluate the AKI-related biomarker levels after cardiac surgery.
Third, the baseline kidney function was different among the recruited patients of these included trials, and this difference might have contributed to different clinical scenarios of de novo AKI following cardiac surgery with CPB. In addition, we lacked access to patient-level data to determine whether cardiac risk factors (e.g., an older age, gender, diabetes and hyperlipidaemia) or concomitant medications (e.g., nitrates, statins, beta-blockers and anaesthetic agents) influence the effects of RIPC on the AKI risk [37] [38] [39] .
Finally, the cardiac surgical procedures of the included trials were different. Among the various cardiac surgical procedures, the risk of postoperative AKI was different. For instance, it increased with valvular heart surgery, especially with double aortic and mitral valve surgery, a procedure involving the mitral valve, reoperation and concomitant CABG [40, 41] . The majority of patients in these trials underwent CABG, valvular heart surgery or their combination. However, the accessible data were too scarce for us to carry out a sub-group analysis to assess appropriately whether the covariate contributed significantly to heterogeneity.
CONCLUSIONS
In conclusion, in the present meta-analysis, we demonstrate that RIPC reduces the incidence of AKI among adult patients undergoing cardiac surgery with CPB. Moreover, these benefits offered by RIPC were found to be associated with the definition of AKI. In addition, we also conclude that RIPC performed on the lower limb or with the total duration of ischaemia <20 min renders the best benefit. However, due to the major limitations of the small sample size and variations of the surgical procedures and basal characteristics of the participants recruited in these trials, our conclusions need to be further corroborated in future studies.
